289 related articles for article (PubMed ID: 32750664)
21. Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data.
Naaber P; Hunt K; Pesukova J; Haljasmägi L; Rumm P; Peterson P; Hololejenko J; Eero I; Jõgi P; Toompere K; Sepp E
PLoS One; 2020; 15(10):e0237548. PubMed ID: 33108380
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.
Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
J Appl Lab Med; 2020 Sep; 5(5):908-920. PubMed ID: 32428207
[TBL] [Abstract][Full Text] [Related]
23. Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays.
Kweon OJ; Lim YK; Kim HR; Kim MC; Choi SH; Chung JW; Lee MK
PLoS One; 2020; 15(10):e0240395. PubMed ID: 33091042
[TBL] [Abstract][Full Text] [Related]
24. Sensitivity of point-of-care IgM and IgG test in critically ill patients with SARS-Cov-2.
Nguyen LS; Laghlam D; De Gonfreville E; Pène F; Rozenberg F; Mira JP
Crit Care; 2020 Sep; 24(1):573. PubMed ID: 32972451
[No Abstract] [Full Text] [Related]
25. Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays.
Kohmer N; Westhaus S; Rühl C; Ciesek S; Rabenau HF
J Clin Virol; 2020 Aug; 129():104480. PubMed ID: 32505777
[TBL] [Abstract][Full Text] [Related]
26. Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.
Xiang F; Wang X; He X; Peng Z; Yang B; Zhang J; Zhou Q; Ye H; Ma Y; Li H; Wei X; Cai P; Ma WL
Clin Infect Dis; 2020 Nov; 71(8):1930-1934. PubMed ID: 32306047
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal Change of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Patients with Coronavirus Disease 2019.
Zhang G; Nie S; Zhang Z; Zhang Z
J Infect Dis; 2020 Jun; 222(2):183-188. PubMed ID: 32358956
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma.
Bundschuh C; Egger M; Wiesinger K; Gabriel C; Clodi M; Mueller T; Dieplinger B
Clin Chim Acta; 2020 Oct; 509():79-82. PubMed ID: 32526218
[TBL] [Abstract][Full Text] [Related]
29. Serological chemiluminescence immunoassay for the diagnosis of SARS-CoV-2 infection.
Lijia S; Lihong S; Huabin W; Xiaoping X; Xiaodong L; Yixuan Z; Pin H; Yina X; Xiaoyun S; Junqi W
J Clin Lab Anal; 2020 Oct; 34(10):e23466. PubMed ID: 32671890
[TBL] [Abstract][Full Text] [Related]
30. Rapid Detection of COVID-19 by Serological Methods and the Evaluation of Diagnostic Efficacy of IgM and IgG.
Huang S; Lin C; Yan M; Li H; Liu T; Michael W; Xiang J; Shen C
Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180423
[TBL] [Abstract][Full Text] [Related]
31. Cross-Comparison of a Chemiluminescent Platform and a Commercial Receptor Binding Domain-Based ELISA for Detecting SARS-CoV-2 IgG.
Antoine-Reid T; Malone J; Maris AS; White-Abell J; Schmitz JE
J Appl Lab Med; 2020 Nov; 5(6):1416-1420. PubMed ID: 32750140
[No Abstract] [Full Text] [Related]
32. Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies up to 25 April 2020 and public health implications.
Caini S; Bellerba F; Corso F; Díaz-Basabe A; Natoli G; Paget J; Facciotti F; De Angelis SP; Raimondi S; Palli D; Mazzarella L; Pelicci PG; Vineis P; Gandini S
Euro Surveill; 2020 Jun; 25(23):. PubMed ID: 32553061
[TBL] [Abstract][Full Text] [Related]
33. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19.
Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840
[TBL] [Abstract][Full Text] [Related]
34. Can dried blood spots (DBS) contribute to conducting comprehensive SARS-CoV-2 antibody tests?
Thevis M; Knoop A; Schaefer MS; Dufaux B; Schrader Y; Thomas A; Geyer H
Drug Test Anal; 2020 Jul; 12(7):994-997. PubMed ID: 32386354
[No Abstract] [Full Text] [Related]
35. Reliability and usefulness of a rapid IgM-IgG antibody test for the diagnosis of SARS-CoV-2 infection: A preliminary report.
Spicuzza L; Montineri A; Manuele R; Crimi C; Pistorio MP; Campisi R; Vancheri C; Crimi N
J Infect; 2020 Aug; 81(2):e53-e54. PubMed ID: 32335175
[No Abstract] [Full Text] [Related]
36. Performance evaluation of serological assays to determine the immunoglobulin status in SARS-CoV-2 infected patients.
Wechselberger C; Süßner S; Doppler S; Bernhard D
J Clin Virol; 2020 Oct; 131():104589. PubMed ID: 32810840
[TBL] [Abstract][Full Text] [Related]
37. Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays.
Merrill AE; Jackson JB; Ehlers A; Voss D; Krasowski MD
J Appl Lab Med; 2020 Nov; 5(6):1351-1357. PubMed ID: 32717056
[TBL] [Abstract][Full Text] [Related]
38. Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection.
Serrano MM; Rodríguez DN; Palop NT; Arenas RO; Córdoba MM; Mochón MDO; Cardona CG
J Clin Virol; 2020 Aug; 129():104529. PubMed ID: 32659710
[TBL] [Abstract][Full Text] [Related]
39. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives.
Infantino M; Damiani A; Gobbi FL; Grossi V; Lari B; Macchia D; Casprini P; Veneziani F; Villalta D; Bizzaro N; Cappelletti P; Fabris M; Quartuccio L; Benucci M; Manfredi M
Isr Med Assoc J; 2020 Apr; 22(4):203-210. PubMed ID: 32286019
[No Abstract] [Full Text] [Related]
40. The Promise and Peril of Antibody Testing for COVID-19.
Abbasi J
JAMA; 2020 May; 323(19):1881-1883. PubMed ID: 32301958
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
